The development of primary antibacterial immune protection against Erysipelothrix rhusiopathiae and the effect of anaerobic corynebacterial immunostimulants. (Short communication).
D000276:Adjuvants, Immunologic; D000818:Animals; D001428:Bacterial Vaccines / Q000276:immunology*; D003352:Corynebacterium / Q000276:immunology*; D004888:Erysipelothrix / Q000276:immunology*; D004889:Erysipelothrix Infections / Q000517:prevention & control*; D051379:Mice
D000276:Adjuvants, Immunologic; D001428:Bacterial Vaccines